BRACX | VFICX | BRACX / VFICX | |
Total Expense Ratio | 0.00 | 0.20 | - |
Annual Report Gross Expense Ratio | 0.12 | 0.20 | 60% |
Fund Existence | 21 years | 32 years | - |
Gain YTD | 3.694 | 2.453 | 151% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 440M | 36.5B | 1% |
Annual Yield % from dividends | 5.35 | 4.66 | 115% |
Returns for 1 year | 4.71 | 1.62 | 290% |
Returns for 3 years | 13.39 | 2.03 | 660% |
Returns for 5 years | -4.35 | -16.79 | 26% |
Returns for 10 years | 27.06 | 0.16 | 17,182% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
IVOL | 19.32 | 0.10 | +0.52% |
Quadratic Intrst Rt Vol & Infl H ETF | |||
CPSA | 26.08 | -0.02 | -0.10% |
Calamos S&P 500 Str Alt Prt ETF-Aug | |||
GDO | 11.72 | -0.04 | -0.34% |
Western Asset Global Corporate Opportunity Fund Inc | |||
SPBO | 28.87 | -0.13 | -0.45% |
SPDR® Portfolio Corporate Bond ETF | |||
HELX | 28.06 | -0.30 | -1.06% |
Franklin Genomic Advancements ETF |